Other Healthcare Technology Systems · San Diego, CA · Founded 2017 · Privately Held (backing)
Developer of genetic analysis tools intended to be used for the research and diagnostic markets. Element Biosciences is based in San Diego, CA and was founded in 2017. It is valued at about $1 billion as of Oct 2026, set by institutional fund marks. It has raised $683 million across 2 recorded rounds; the latest was a $277 million Series D in Jul 2024.
PMV mark · valuation
$1.0B
Oct 2026
Priced at
its Series D
Jul 2024
Total raised
$683.3M
Last round
Later Stage VC (Series D)
Jul 2024
No prints on record
No secondary trades in Element Biosciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Element Biosciences stock.
